ARTICLE | Clinical News
HE2000: Phase II
November 19, 2001 8:00 AM UTC
Preliminary results of an open-label Phase II study of HE2000 in Thailand showed that 19 of 21 patients met the primary endpoint of a 50% reduction in malaria parasite count after 7 days. HEPH said th...